In order to obtain data regarding diagnosis and treatment of angina under real ambulatory practice in Ukraine and to estimate the efficacy of secondary prevention we performed screening of 1700 patients. Among them,
1563 patients (62.5 % men and 34.5 % women) requested for medical outpatient aid because of attacks in thorax area verified by physicians as angina episodes. Among men, 61 % were in the age 40–60 years. The
larger part of women (59 %) were more than 60 years. The following risk factors were recognized: adiposity – in 10.2 %, smoking – in 24.6 % men and 3.25 % women, only 19.5 % of patients had regular physical activity.
Among the examined patients the most frequent concomitant diseases were arterial hypertension (81.6 %), heart failure (61.8 %), diabetes mellitus (20 %). More than half of patients had 6 or more angina attacks per
week. 50 % of patients of able-bodied age had a minimum one myocardium infarction. Before being included in the research the treatment included: antiplatelet drugs – in 75.8 % patients, statins – 50.2 %, beta-blockers – 64.9 %, angiotensin-converting enzyme inhibitors – 56.5 %, long-acting nitrates – 51.9 %, calcium antagonists – 18.1 %, molsidomin – 3.2 %, ivabradine – 1.9 %, trimetazidine MR – 9.5 %. It was established that
in most cases the adequacy of primary ischemic heart disease (IHD) diagnosis corresponds to the existing standards; coronary angiography is used insufficiently in IHD or/and efficacy estimation of preventive measures;
the majority of angina patients asking for medical aid belong to the high risk IHD patients of able-bodied age; in treatment of high cardiovascular risk patients the possibilities of contemporary pharmacotherapy are